Evidence map›Paper›PMID 42049698›Full record

ArticleBlood cancer journal2026

Immune effector cell-associated enterocolitis post-BCMA directed CAR T-cell therapy: insights from a multicenter case series.

Sandra Susanibar-Adaniya, Benjamin A Derman, Adam D Cohen, Dan T Vogl, Shambavi Richard, Adriana Rossi, Matthew J Frigualt, Andrew J Yee, Binod Dhakal, Noffar Bar

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sandra Susanibar-AdaniyaAbramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0003-0703-2518
Benjamin A DermanSection of Hematology/Oncology, University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-4070-1819
Adam D CohenAbramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0003-0939-3843
Dan T VoglAbramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-2935-2566
Shambavi RichardDepartment of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0003-0274-4292
Adriana RossiDepartment of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Matthew J FrigualtMassachusetts General Cancer Center and Harvard Medical School, Boston, MA, USA.
Andrew J YeeMassachusetts General Cancer Center and Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-3623-7491
Binod DhakalMedical College of Wisconsin, Milwaukee, WI, USA.ORCID http://orcid.org/0000-0002-4377-9742
Noffar BarYale Cancer Center, Yale University School of Medicine, New Haven, CT, USA. Noffar.bar@yale.edu.ORCID http://orcid.org/0000-0002-8383-1867

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42049698
PMCPMC13125467

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.